A few months ago in Barcelona, at the annual conference of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), thousands of participants from dozens of countries convened for Patient Community Day 2025 (PCD). This annual event brings together researchers focused on multiple sclerosis (MS) and associated…
MS patients
I tend to be a pretty reserved guy. I don’t yell myself hoarse at my children’s sporting events or shout advice to athletes that I happen to be watching live or on TV. I don’t scream, “Look behind you!” or “Don’t go in there!” to characters in a movie either.
Intimacy and sexuality among people with multiple sclerosis (MS) will be the focus of this year’s Holistic Health and Wellness Forum for MS, presented by Yoga Moves MS — a U.S. program aiming to improve quality of life for those with neuromuscular conditions — on May 21 in Michigan…
The patient support program Cycle Vita, which assists patients throughout the process of medical prescriptions, is now available for people taking the multiple sclerosis (MS) medication Bafiertam (monomethyl fumarate). That’s according to Cycle Pharmaceuticals, in an announcement a few months after the company acquired Banner…
Nearly 50% of people with multiple sclerosis (MS) report pronounced fatigue, which has a significantly negative effect on their well-being, a new study from Finland has found. In an analysis of data from more than 500 patients from the Finnish MS registry, individuals with self-perceived fatigue were more likely…
Cognitive impairment is common in people with multiple sclerosis (MS) who have not previously received treatment, affecting about 1 in 4 patients, and rates are particularly higher in those with secondary progressive MS (SPMS), a new study found. “The current study demonstrates that a significant portion of MS…
Interactions between the body’s immune system and bacteria that live in the digestive tract — essentially, a person’s gut — become disrupted in multiple sclerosis (MS), a new study by U.S. researchers found. The human intestines are home to billions of bacteria and other microorganisms, collectively known as the…
Nearly all adults with relapsing forms of multiple sclerosis (MS) said they are highly satisfied with the Sensoready autoinjector pen to self-administer Kesimpta (ofatumumab), according to a recent U.S. survey. High satisfaction was mainly driven by the reasonable administration time and ease of use, the researchers said. The…
While people with multiple sclerosis (MS) seem to get a similar quantity of sleep relative to individuals without the disease, MS patients have significantly worse sleep quality than their healthy counterparts, according to a new review of several published studies. The findings show that MS may affect a person’s…
Gadoquatrane, a contrast agent Bayer is developing for use in MRI scans, is able to detect regions of damage and other disease-related features while using 60% less gadolinium — a chemical element used to enhance an MRI — compared with existing gadolinium-based contrast agents. That’s according to new data…
People with multiple sclerosis (MS) who undergo an autologous hematopoietic stem cell transplant (HSCT) — which uses a patient’s own stem cells — face unique physical and emotional challenges at every stage of the process, from balancing hope and fear when deciding on moving forward with the treatment…
Multiple sclerosis (MS) patients exhibited greater resistance to the effects of insulin — the hormone responsible for keeping the body’s blood sugar levels within a healthy range — and had higher overall insulin levels compared with people without the neurodegenerative disease, a meta-analysis of published studies found. These findings…
I used to think I was immune to illness. Getting sick was what my patients did. My multiple sclerosis (MS) diagnosis turned this belief, and many others, upside down. When the chaos of the diagnosis settled, I realized that becoming a patient was the most profound lesson I could…
People with multiple sclerosis (MS) who received a university-level education are more likely to be on disease-modifying treatment (DMT) in regions with a publicly funded healthcare system, a U.K.-based study suggests. Advanced education was also linked to treatment starting faster and high-efficacy…
Treatment with Ocrevus (ocrelizumab) may stabilize disability progression in people with multiple sclerosis (MS) who have severe walking impairments — a patient group excluded from clinical trials supporting the therapy’s 2017 approval — a real-world analysis suggests. However, about half of those receiving Ocrevus in this study discontinued…
People with multiple sclerosis (MS) engage in significantly more sedentary behaviors — activities like watching TV or using a computer or smartphone versus those requiring physical movement, such as exercise — than do individuals without the progressive disease, according to a pooled analysis of published studies. This effect was…
People with multiple sclerosis (MS) in the United Kingdom are less likely to be on disease-modifying treatments (DMTs) compared with MS patients in other countries in Europe, a new study reports. “We know that getting early treatment with disease-modifying MS therapies can improve long term health and wellbeing.
The government of Canada soon will provide new income benefits designed to help Canadians living with a disability — including people with multiple sclerosis (MS). Applauded by MS Canada, a nonprofit that actively advocated for these benefits, the announcement follows the passing of the Canada Disability Benefit Act,…
People with multiple sclerosis (MS) should generally follow a regular vaccination schedule similar to their healthy peers, with certain adjustments made if they’re on particular disease-modifying therapies (DMTs), according to a group of experts in Europe who devised a set of more than 50 evidence-based guidelines for the…
Nearly half of multiple sclerosis (MS) patients experience swallowing difficulties, which is notably higher than rates seen in the general population, according to a recent review study and meta-analysis. Because swallowing problems, or dysphagia, can lead to serious, sometimes life-threatening, complications, it is important for patients to be routinely…
About one in five people with multiple sclerosis (MS) may be unfit to drive a vehicle due to disease-related difficulties, according to a review of published studies. Cognitive and visual difficulties were most frequently associated with impaired driving ability, both on the road and in a simulation. However, the…
XRHealth‘s virtual reality (VR) software, which provides an immersive three-dimensional environment where patients do repetitive tasks such as popping a balloon with a sword, is safe and feasible for upper limb training among people with multiple sclerosis (MS), according to a recent pilot study. Participants generally felt engaged…
Using wearable sensors to monitor gait during daily life may be a promising way to identify people with multiple sclerosis (MS) who have a greater risk of falling, a study found. The study identified a number of gait differences between those who fell in the year and those who…
Doctors typically prescribe medications to help manage symptoms of multiple sclerosis (MS), but a veteran nonprofit focuses on a little-known, much-overlooked part of treatment: therapeutic adventuring. First Descents was founded in 2001 to bring free outdoor activities to young adults with cancer. After a successful pilot study,…
The Accelerated Cure Project (ACP) for multiple sclerosis (MS) is teaming up with Quest Diagnostics to study how MS patients respond to COVID-19 vaccines. “Understanding the immune response to the COVID-19 vaccine doses in a longer-term study in people with MS will provide tremendous insights into not…
People who underwent a hematopoietic stem cell transplant (HSCT), many of them patients with multiple sclerosis (MS), were supportive of the treatment despite its high costs — and hesitancy and opposition from their neurologists — a survey study showed. Most surveyed HSCT recipients — about 85% — believed…
This column is being published on April 1. When I was in the journalism profession, that was a day we had to be on guard against pranksters who would try to trick us into reporting phony April Fools’ Day news items. So, I need to be very clear about this…
Never having been offered, let alone received any disease modifying therapy, I can address the subject of disease modifying therapies, and their side effects, with complete impartiality. Of course, the reason for the lack of any medication is because none has yet been approved for use with MS patients who…